1Janssen-Heijnen ML, Smulders S, Lem mens VE, et al. Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax,2004,59(7) : 602-607.
4Langer CJ, Manola J, Bernardo P, et al.Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer:implications of Eastern Cooperative Oncology Group 5592, a randomized trial. J Natl Cancer Inst,2002,94(3) : 173-181.
二级参考文献8
1孙燕 周际昌.临床肿瘤内科手册[M].北京:人民卫生出版社,1996.30-33.
2Spiro SG, Porter JC. Lung cancer-where are we today?Current advances in staging and nonsurgical treatment[J]. Am J Respir Crit Care Med, 2002, 166(9): 1166.
3Langer CJ, Manola J, Bernardo P, et al. Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of eastern cooperative oncology group 5592, a randomized trial[J]. J Natl Cancer Inst,2002, 94(3): 173.
5Clegg A, Scott DA, Hewitson P, et al. Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review[J]. Thorax, 2002, 57(1): 20.
